Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control
Exor’s investment in Philips will not result in any share dilution and has been carried out by way of on-market share purchases
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
JDHL has a strong reputation as an end-to-end design-focused manufacturer of electro-medical devices
Subscribe To Our Newsletter & Stay Updated